AN1 FY26-Appendix-4E-

Key points

• Revenue increased by 0.80% to $5,159,679
• Net profit from ordinary activities increased by $308,472
• No dividends paid, recommended, or declared
• Net tangible asset backing per ordinary security: 0.23 cent
• Number of shares on issue increased to 985.5 million

Full summary

Anagenics Limited (ASX: AN1) has released its preliminary final report for the financial year ended 30 June 2026. The company reported a revenue increase of 0.80% to $5,159,679, with net profit from ordinary activities rising by $308,472. Notably, no dividends were paid, recommended, or declared during the period. The number of shares on issue increased to 985.5 million from 496.3 million in the previous year. The net tangible asset backing per ordinary security stood at 0.23 cent, up from -0.03 cent in the previous year. The financial statements have been audited by Stannards Audit Pty Ltd, which issued an unmodified audit report.